The idea is show drug of interest is not affecting functional ability of these

I'm thinking along the lines of:

1. Stimulate primary macrophages (or just Raw 264.7 cells) with LPS and treat with drug of interest. Label the macrophages and run on flowcytometry.

It doesn't sound right to just do this or may be I'll have to test for engulfment of FITC zymosan beads etc as the idea is to test the ability. Any thoughts?

2. Activate B cells with LPS/IL4 and treat with drug of interest, Measure IgG1? I'm not sure if this is called quicker as minimum activation period is 12-24 hrs. Any other way? IgM would be quicker ?

Similar questions and discussions